ReviewJournal of global oncology2018
Global Challenges for Cancer Imaging.
Abstract readReview
In one paragraph
Review in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Referral delays in metastatic breast cancer care: barriers and facilitators across a fragmented pathway.BMJ open quality · 2026Article
- LungCNET: A High-Performance Deep CNN Model for Lung Cancer Detection Evaluated Against Widely Used CNN Benchmarks.Bioengineering (Basel, Switzerland) · 2026Article
- Machine learning-guided multimodal profiling defines perturbed immune states at the time of cancer diagnosis.Briefings in bioinformatics · 2026Article
- Contextual structured annotations on PACS: a futuristic vision for reporting routine oncologic imaging studies and its potential to transform clinical work and research.Abdominal radiology (New York) · 2026Review
- 'Challenges and opportunities for imaging on a global scale' special collection-introductory editorial.BJR open · 2026Article
- Large Language Models in Cancer Imaging: Applications and Future Perspectives.Journal of clinical medicine · 2025Review
- Machine learning framework to extract the biomarker potential of plasma IgG N-glycans towards disease risk stratification.Computational and structural biotechnology journal · 2024Article
- Perceptions of radiologists on structured reporting for cancer imaging-a survey by the European Society of Oncologic Imaging (ESOI).European radiology · 2024Article
- Disparities in stage at diagnosis for liver cancer in China.Journal of the National Cancer Center · 2023Article
- Effects of Expert-Determined Reference Standards in Evaluating the Diagnostic Performance of a Deep Learning Model: A Malignant Lung Nodule Detection Task on Chest Radiographs.Korean journal of radiology · 2023Article
- Challenges in the diagnosis and management of IBD: a sub-Saharan African perspective.Therapeutic advances in gastroenterology · 2023Review
- Review
- Responsive Web-based Breast Imaging Core Curriculum for International Radiology Residents with Self-Assessment: A Pilot Study.Academic radiology · 2022Article
- Quality Assurance of a Cross-Border and Sub-Specialized Teleradiology Service.Healthcare (Basel, Switzerland) · 2022Article
- Iodine-Rich Nanoadjuvants for CT Imaging-Guided Photodynamic Immunotherapy of Breast Cancer.Frontiers in bioengineering and biotechnology · 2022Article
- Nanoparticles and convergence of artificial intelligence for targeted drug delivery for cancer therapy: Current progress and challenges.Frontiers in medical technology · 2022Review
- Radiology reporting in oncology-oncologists' perspective.Cancer imaging : the official publication of the International Cancer Imaging Society · 2021Article
- Point-Based Brachytherapy in Cervical Cancer With Limited Residual Disease: A Low- and Middle-Income Country Experience in the Era of Magnetic Resonance-Guided Adaptive Brachytherapy.JCO global oncology · 2021Article
- Contribution of Tata Memorial Centre, India, to cervical cancer care: Journey of two decades.The Indian journal of medical research · 2021Review
- Medical imaging and nuclear medicine: a Lancet Oncology Commission.The Lancet. Oncology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Heinz-Peter SchlemmerHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Leonardo K BittencourtHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Melvin D'AnastasiHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Romeu DominguesHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Pek-Lan KhongHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Zarina LockhatHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Ada MuellnerHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Maximilian F ReiserHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Richard L SchilskyHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Hedvig HricakHeinz-Peter Schlemmer, German Cancer Research Center, Heidelberg; Melvin D'Anastasi and Maximilian F. Reiser, Ludwig-Maximilians-University Hospital, Munich, Germany; Leonardo K. Bittencourt, Fluminense Federal University, Niterói; Leonardo K. Bittencourt and Romeu Domingues, Clínica de Diagnóstico por Imagem (CDPI/Dasa), Rio de Janeiro, Brazil; Pek-Lan Khong, University of Hong Kong, Queen Mary Hospital, Hong Kong, China; Zarina Lockhat, University of Pretoria, Steve Biko Academic Hospital, Pretoria, South Africa; Ada Muellner and Hedvig Hricak, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Imaging plays many essential roles in nearly all aspects of high-quality cancer care. However, challenges to the delivery of optimal cancer imaging in both developing and advanced countries are manifold. Developing countries typically face dramatic shortages of both imaging equipment and general radiologists, and efforts to improve cancer imaging in these countries are often complicated by poor infrastructure, cultural barriers, and other obstacles. In advanced countries, on the other hand, although imaging equipment and general radiologists are typically accessible, the complexity of oncologic imaging and the need for subspecialists in the field are largely unrecognized; as a result, training opportunities are lacking, and there is a shortage of radiologists with the necessary subspecialty expertise to provide optimal cancer care and participate in advanced clinical research. This article is intended to raise awareness of these challenges and catalyze further efforts to address them. Some promising strategies and ongoing efforts are reviewed, and some specific actions are proposed.
Indexed as
Radiation OncologyDelivery of Health CareDeveloped CountriesDeveloping CountriesGlobal HealthHealth Care CostsHealth Services AccessibilityHumansNeoplasmsProfessional Competence
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.